A review study found resistance training, Pilates, and HIIT were linked to lower levels of the nerve damage biomarker NfL in ...
The most protective approach is a balanced routine that includes regular cardio At 65, she feels younger than she did at 45. Dubai-based Anuradha Chatterjee feels that she is living her second life.
Credit: Getty Images Researchers discuss the potential neurologic effects of the menopausal transition on cognitive decline and multiple sclerosis progression. Menopause is increasingly recognized as ...
The impacts of living with a chronic health condition, such as multiple sclerosis (MS), are not always visible to others. This can create unique challenges as individuals navigate treatment plans and ...
University of Connecticut physical therapy professor Dr. Cristina Colón-Semenza saw a 2019 article in the Journal of the American Medical Association about exercise as an effective method to manage ...
Irisin, a hormone released during exercise, appears to directly shield neurons from damage in a mouse model of multiple sclerosis. An experimental gene therapy raised blood levels of the hormone, ...
University of Connecticut physical therapy professor Dr. Cristina Colón-Semenza saw a 2019 article in the Journal of the American Medical Association about exercise as an effective method to manage ...
Summary: A neuroimmunology study uncovered the cellular mechanism decoding why exercise improves neurological symptoms in multiple sclerosis (MS). The research demonstrates that irisin, a hormone ...
A new study offers clues as to why exercise can improve neurological symptoms in people with multiple sclerosis (MS). The study, led by investigators from Mass General Brigham and University Medical ...
Maggie Aime has over 25 years of experience in healthcare and as a nurse across specialties including oncology, kidney transplant, cardiology, and more. She leverages her rich healthcare experience to ...
Neuraly, Inc., a wholly owned subsidiary of D&D Pharmatech, Inc. (KOSDAQ: 347850), announced that the first patient has been dosed in a Phase 2 Investigator-Initiated Trial (IIT) evaluating ...